Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.
Overview
Healthcare investors often choose between capturing the entire sector versus targeting high-growth sub-industries such as biotechnology.
The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) provides broad, low-cost exposure to the full healthcare sector, whereas the VanEck Biotech ETF (NASDAQ:BBH) offers a concentrated, higher-fee play specifically on biotechnology innovators. Here's how these two ETFs compare on risk, performance, fees, and other factors that matter for investors.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Details
Source
Originally published at www.fool.com.